Sulfacetamide sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulfacetamide sodium and what is the scope of freedom to operate?
Sulfacetamide sodium
is the generic ingredient in seventeen branded drugs marketed by Bausch, Fougera Pharms, Padagis Us, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Epic Pharma Llc, Sola Barnes Hind, Novartis, Optopics, Alcon Pharms Ltd, Bausch And Lomb, Sandoz, and Sciegen Pharms Inc, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for sulfacetamide sodium. Thirteen suppliers are listed for this compound.
Summary for sulfacetamide sodium
| US Patents: | 0 |
| Tradenames: | 17 |
| Applicants: | 17 |
| NDAs: | 30 |
| Drug Master File Entries: | 1 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 2 |
| Patent Applications: | 46 |
| What excipients (inactive ingredients) are in sulfacetamide sodium? | sulfacetamide sodium excipients list |
| DailyMed Link: | sulfacetamide sodium at DailyMed |
Recent Clinical Trials for sulfacetamide sodium
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chang Gung Memorial Hospital | Phase 1/Phase 2 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | N/A |
Pharmacology for sulfacetamide sodium
| Drug Class | Sulfonamide Antibacterial |
Medical Subject Heading (MeSH) Categories for sulfacetamide sodium
Anatomical Therapeutic Chemical (ATC) Classes for sulfacetamide sodium
US Patents and Regulatory Information for sulfacetamide sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SULF-10 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080025-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Miza Pharms Usa | OCUSULF-10 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080660-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Miza Pharms Usa | OCUSULF-30 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080660-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
